CIK 0001237831
- Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043744954
- Phone
- +1 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,794,049
- in 3 filings, $425K under 10b5-1 plans
Net −$5,794,049. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 40 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-21 | Pfeil Keith W President, CEO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +100,000 | 100,000 | ||
| 2025-07-18 | Pfeil Keith W President, CEO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +40,000 | 40,000 | ||
| 2025-01-23 | Pfeil Keith W COO, CFO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +60,000 | 60,000 | ||
| 2025-01-10 | Pfeil Keith W COO, CFO | Exercise or conversion 10b5-1 | +5,833 | $49.65 | $290K | 5,833 |
| 2025-01-10 | Pfeil Keith W COO, CFO | Exercise or conversion 10b5-1 | +8,334 | $53.27 | $444K | 14,167 |
| 2025-01-10 | Pfeil Keith W COO, CFO | Sale 10b5-1 | −12,501 | $88.17 | $1.1M | 1,666 |
| 2025-01-10 | Pfeil Keith W COO, CFO | Sale 10b5-1 | −1,666 | $89.17 | $149K | 0 |
| 2025-01-10 | Pfeil Keith W COO, CFO | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −5,833 | 0 | ||
| 2025-01-10 | Pfeil Keith W COO, CFO | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −8,334 | 833 | ||
| 2024-01-26 | Pfeil Keith W SVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +60,000 | 60,000 | ||
| 2023-10-10 | Pfeil Keith W SVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +5,000 | 5,000 | ||
| 2023-02-02 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion | +14,167 | $49.65 | $703K | 14,167 |
| 2023-02-02 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion | +15,000 | $53.27 | $799K | 29,167 |
| 2023-02-02 | Pfeil Keith W SVP, Chief Financial Officer | Sale | −29,167 | $77.57 | $2.3M | 0 |
| 2023-02-02 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −14,167 | 5,833 | ||
| 2023-02-02 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −15,000 | 9,167 | ||
| 2023-01-26 | Pfeil Keith W SVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +40,000 | 40,000 | ||
| 2022-01-27 | Pfeil Keith W SVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +40,000 | 40,000 | ||
| 2021-08-19 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion | +833 | $49.65 | $41K | 833 |
| 2021-08-19 | Pfeil Keith W SVP, Chief Financial Officer | Sale | −833 | $76.13 | $63K | 0 |
Page 1 of 3 · 45 trades